Goldman Sachs analyst Lizzie Dove initiated coverage on Aramark (NYSE:ARMK) with a Buy rating and a price target of $33. Dove's analysis suggests that Aramark is at an inflection point for pricing growth due to the typical 18-month lag in passing through inflation in food input prices. The company's exposure to Education, Corrections, and Healthcare segments indicates potential upside in fiscal years 2024-2025. Aramark's net new business has significantly increased, and the trend towards outsourcing is expected to continue, which could lead to positive margin flow-through. Dove also notes that a deceleration in the CPI food away from home index could benefit Aramark's F2024 margin outlook. Additionally, expected rate cuts in 2024 could lower interest costs and increase investor appetite for levered stocks like Aramark. The stock is currently trading slightly lower at $28.85.